Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma.

Chiyu HeWei ShenZuyuan LinZhihang HuHuigang LiHao ChenModan YangXinyu YangJianyong ZhuoLinhui PanXuyong WeiLi ZhuangShusen ZhengDi LuXiao Xu

Published in: Transplant immunology (2024)

Both pre-LT PLR and post-LT PLR demonstrated prognostic value in patients following LT for HCC. Monitoring PLR values based on the MELD score can improve the predictive prognosis and more effectively guide the individual decisions for the postoperative intervention.

Keyphrases

end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported